Interview with Pierre Boyer, Servier Czech Republic
You joined this affiliate in October of 2011, having spent the preceding three years as GM for Servier Slovakia. What are the principal differences you found between these two markets?…
Address: SERVIER s.r.o., Praha City Center, Klimentská 46, 110 02, Prague,Czech Republic
Tel: +420 222 118 111
Servier started its activities in the Czech Republic in October of 1994. Throughout its years on the Czech pharmaceutical market, the company has built a strong position in the field of cardiology, diabetology, internal medicine, psychiatry and angiology. Servier’s drugs have been used by more than 800,000 Czech patients.
In 1998, Servier CZ established a research center for clinical development, based in Prague. The aim of the center is to organize clinical trials in accordance with Good Clinical Practice (GCP) and local laws.
In 2012, Servier ranked among the top five major pharmaceutical companies in the Czech Republic. The company has long been one of the most dynamic organizations in the Czech pharmaceutical market.
Innovative pharmaceutical products in the fields of cardiology, diabetology, internal medicine, psychiatry and angiology.
You joined this affiliate in October of 2011, having spent the preceding three years as GM for Servier Slovakia. What are the principal differences you found between these two markets?…
A cross-industry push for better and broader access to innovative treatments is underway in the Czech Republic. Ripe for reform is the country’s orphan drug legislation as no standard pathway…
Jiří Lukeš, of B Braun Czech Republic, introduces the success of the affiliate he helped establish over 27 years ago, and why he feels that the local business is doing…
Petr Vaculík, country manager of PSI CRO, a privately owned Swiss clinical research organization (CRO), describes how the number of clinical trials is decreasing in the Czech Republic, although many…
Tamer Shawky, general manager Central Region for J&J Medical Devices, shares his first expectations arriving into the region three years ago, following a successful career in the Middle East and…
Olga Starobová, medical director of Syneos Health Czech Republic, walks us through the steps put in place to ensure successful synergies during the merger between INC Research and InVentiv Health,…
Kostas Deligiannis, general manager Eastern Europe for GE Healthcare (GEHC), outlines GE Healthcare’s commitment to the 20-country region under his remit, his priorities for greater collaboration between these countries, and…
Paul-François Cossa, country chair of Sanofi Czech Republic & Slovakia and General Manager CHC, reviews the outstanding performance of the company in 2019, breaks down his new vision for Sanofi…
Pavla Rozmarová, clinical research associate manager & regional OD for the Czech affiliate of German CRO Scope International, describes how the Czech clinical research landscape has evolved in the past…
Roman Badik, CEO of Enantis, the first biotechnology spin-off from Masaryk University in the Czech Republic, shares his vision of turning the company’s research breakthroughs into a self-sustaining business. Badik…
Augustin Bernát, general manager for the Czech affiliate of ResMed, a company whose cloud-connected medical devices transform care for people with sleep apnea, COPD and other chronic diseases, discusses how…
Among the seven insurance funds in the Czech Republic, VZP is the largest with six million clients and the widest network of health service providers. David Šmehlík, the organisation’s deputy…
Martin Puchwein, country president for Novartis Group Czech Republic, and general manager for pharma, shares his perspectives on launching innovative drugs in the country, including some new therapeutic approaches such…
See our Cookie Privacy Policy Here